Liquid biopsy in prostate cancer

Liquid biopsy in prostate cancer - LiBiPros

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON49655

Enrollment

100

Registered

2020-02-12

Start date

2020-06-29

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

metastasized castrate-resistant prostate cancer prostate carcinoma

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - patients with metastasized castrate-resistant prostate carcinoma (mCRPC) - patients with metastasized hormone-sensitive prostate carcinoma (mHSPC)

Exclusion criteria

Exclusion criteria: - no other malignancies - no biopt of the prmary tumor - patients treated with radio-isotopes - no informed consent

Design outcomes

Primary

Measure	Time frame
- relation between de absence/presence of specific mutations in blood vs primary tumor (with special attention to AR-V7 and BRCA 1/2) - response on therapie	—

Secondary

Measure	Time frame
- relation between de absence/presence of specific mutations in urine vs peripheral blood (with special attention to AR-V7 and BRCA 1/2) - response on therapie	—

Countries

Netherlands

Outcome results